Stericycle - SRCL Stock Forecast, Price & News

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Stericycle in the last year. There are currently 2 hold ratings and 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "hold" SRCL shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in SRCL, but not buy additional shares or sell existing shares.
View SRCL analyst ratings or view top-rated stocks.

3 brokerages have issued 12-month target prices for Stericycle's stock. Their SRCL share price forecasts range from $46.00 to $63.00. On average, they predict the company's share price to reach $54.50 in the next twelve months. This suggests a possible upside of 7.7% from the stock's current price.
View analysts price targets for SRCL or view top-rated stocks among Wall Street analysts.

Stericycle's stock was trading at $59.64 on January 1st, 2022. Since then, SRCL shares have decreased by 15.1% and is now trading at $50.61.
View the best growth stocks for 2022 here.

The company is scheduled to release its next quarterly earnings announcement on Thursday, February 23rd 2023.
View our SRCL earnings forecast.

Stericycle, Inc. (NASDAQ:SRCL) released its quarterly earnings data on Thursday, November, 3rd. The business services provider reported $0.65 earnings per share for the quarter, topping the consensus estimate of $0.58 by $0.07. The business services provider had revenue of $690.30 million for the quarter, compared to the consensus estimate of $675.21 million. Stericycle had a trailing twelve-month return on equity of 7.10% and a net margin of 0.26%. The business's quarterly revenue was up 6.4% on a year-over-year basis. During the same quarter in the prior year, the firm posted $0.44 earnings per share.

Stericycle updated its FY 2022 earnings guidance on Tuesday, November, 8th. The company provided earnings per share guidance of $2.00-$2.15 for the period, compared to the consensus earnings per share estimate of $2.05. The company issued revenue guidance of -.

132 employees have rated Stericycle Chief Executive Officer Cindy Miller on Glassdoor.com. Cindy Miller has an approval rating of 74% among the company's employees.

Based on aggregate information from My MarketBeat watchlists, some companies that other Stericycle investors own include Procter & Gamble (PG), Intel (INTC), NVIDIA (NVDA), Starbucks (SBUX), Walt Disney (DIS), QUALCOMM (QCOM), Johnson & Johnson (JNJ), AbbVie (ABBV), Fastenal (FAST) and Gilead Sciences (GILD).

Stericycle trades on the NASDAQ under the ticker symbol "SRCL."

Stericycle's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Vanguard Group Inc. (9.42%), BlackRock Inc. (8.09%), Alliancebernstein L.P. (7.42%), Price T Rowe Associates Inc. MD (6.93%), Clarkston Capital Partners LLC (6.17%) and Impax Asset Management Group plc (3.03%). Insiders that own company stock include Daniel Ginnetti, David W Stahl and Stephen Cory White.
View institutional ownership trends.

Shares of SRCL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of SRCL stock can currently be purchased for approximately $50.61.

Stericycle (NASDAQ:SRCL) has a market capitalization of $4.67 billion and generates $2.65 billion in revenue each year. The business services provider earns $-27,800,000.00 in net income (profit) each year or $0.07 on an earnings per share basis.

The company employs 15,000 workers across the globe.

Stericycle's mailing address is 2355 WAUKEGAN ROAD, BANNOCKBURN IL, 60015. The official website for the company is www.stericycle.com. The business services provider can be reached via phone at (847) 367-5910, via email at investor@stericycle.com, or via fax at 847-367-9493.